47 related articles for article (PubMed ID: 2143104)
1. Safety and pharmacokinetics of intravenously administered trospectomycin sulfate.
Novak E; Griffith DL; Paxton LM; Metzler CM; Bye A
Clin Ther; 1990; 12(3):269-80. PubMed ID: 2143104
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose, double-blind, placebo controlled intravenous tolerance and pharmacokinetic study of trospectomycin sulfate (U-63, 366F) in healthy male volunteers.
Peters GR; Novak E; Batts DH; Bye A; Nichols DJ; Francom SF
Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):361-8. PubMed ID: 2146231
[TBL] [Abstract][Full Text] [Related]
3. Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).
Novak E; Paxton LM; Bye A; Patel R; Zurenko GE; Francom SF
Antimicrob Agents Chemother; 1990 Dec; 34(12):2342-7. PubMed ID: 2150907
[TBL] [Abstract][Full Text] [Related]
4. Distribution and disposition of trospectomycin sulfate in the in vivo rat, perfused rat liver, and cultured rat hepatocytes.
Cox JW; Dring LG; Ginsberg LC; Larson PG; Constable DA; Ulrich RG
Drug Metab Dispos; 1990; 18(5):726-31. PubMed ID: 1981727
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and fate of [3H]trospectomycin sulfate, a novel aminocyclitol antibiotic, in male and female dogs and rabbits. Allometric scaling with human.
Nichols DJ; Burrows M; Bye A; Constable DA; Dring LG; Jeffrey P
Drug Metab Dispos; 1991; 19(4):781-6. PubMed ID: 1680655
[TBL] [Abstract][Full Text] [Related]
8. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses.
Nichols DJ; Bye A; Novak E
Br J Clin Pharmacol; 1991 Aug; 32(2):255-7. PubMed ID: 1834145
[TBL] [Abstract][Full Text] [Related]
11. Trospectomycin, a novel spectinomycin analogue: antibacterial activity and preliminary human pharmacokinetics.
Zurenko GE; Ford CW; Novak E
Drugs Exp Clin Res; 1988; 14(6):403-9. PubMed ID: 2975212
[TBL] [Abstract][Full Text] [Related]
12. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
[TBL] [Abstract][Full Text] [Related]
13. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
14. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
Lasseter KC; Shaughnessy L; Cummings D; Pezzullo JC; Wargin W; Gagnon R; Oliva J; Kosutic G
J Clin Pharmacol; 2008 Feb; 48(2):193-202. PubMed ID: 18199894
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man.
Boneu B; Necciari J; Cariou R; Sié P; Gabaig AM; Kieffer G; Dickinson J; Lamond G; Moelker H; Mant T
Thromb Haemost; 1995 Dec; 74(6):1468-73. PubMed ID: 8772222
[TBL] [Abstract][Full Text] [Related]
20. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
